Valuation eFFECTOR Therapeutics, Inc.

Stocks

Real-time OTC Markets 18:33:11 29/05/2026 +04			5-day change	1st Jan Change
0.000600 ^USD	+20.00%		-25.00%	+200.00%

11/09/24	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
08/07/24	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	16/03/22	08/03/23	26/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EFFECTOR THERAPEUTICS, INC.	-	-	-	-	3.76K
WUXI APPTEC CO., LTD.	20.63x	7.28x	14.62x	1.44%	70.24B
ARGENX SE	32.28x	9.34x	45.05x	0.04%	62.63B
INSMED INCORPORATED	-76.7x	14.8x	-71.37x	-.--%	27.36B
WUXI BIOLOGICS (CAYMAN) INC.	29.77x	6.32x	16.41x	-.--%	25.71B
BIONTECH SE	-15.03x	5.62x	-7.06x	-.--%	24.83B
GENMAB A/S	26.45x	5.03x	16.73x	-.--%	19.52B
PHARMAESSENTIA CORPORATION	44.88x	16.47x	33.42x	0.34%	15.51B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1267.62x	36.68x	797.93x	-.--%	14.66B
SUMMIT THERAPEUTICS INC.	-15.8x	3569.89x	-18.25x	-.--%	14.69B
Average	146.01x	407.94x	91.94x	0.2%	27.52B
Weighted average by Cap.	77.53x	200.44x	52.40x	0.4%